Sigma Healthcare Limited’s (ASX: SIG) half year results were in line with the expectation of the company. Ongoing revenue was up by 6.9% for the first half. The company reported an underlying EBITDA of $31.9 million.
- Project Pivot is on target to deliver $100+ million efficiency gains;
- Actions already implemented on over $33 million of annualised gains;
- Net debt decreased from $243 million at year end to $193 million at 31st July 2019;
- Dividend payout ratio of 95% of Underlying PAT;
At AEST 01:26PM, the stock was trading at $0.590 per share, up by 2.609% from its previous close.